| Analysis | Metabolite Name | Measured Value | Units | Source |
|---|---|---|---|---|
| GCMS positive ion mode | lyxitol | 106.3394683 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 113.5298058 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 116.3434903 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 118.556701 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 124.0740741 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 124.9173827 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 126.4214047 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 129.707113 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 129.8076923 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 133.5078534 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 143.6672968 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 153.1229013 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 155.917345 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 155.9495192 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 161.8257261 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 162.9327902 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 167.1223513 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 169.9457259 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 171.9442685 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 175.3554502 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 178.3887468 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 181.1207472 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 183.480454 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 184.0909091 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 188.4758364 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 189.8263027 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 190.3353057 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 190.7456724 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 193.006993 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 193.8202247 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 198.769008 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 199.0773598 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 201.4285714 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 206.4989518 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 207.2864322 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 208.0808081 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 208.3333333 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 211.0224801 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 214.8648649 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 215.6019656 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 220.1086957 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 223.2375979 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 224.522293 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 234.6368715 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 236.8944924 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 237.4371859 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 237.7919321 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 238.0271623 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 241.8699187 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 242.1052632 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 243.0330525 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 245.0160772 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 246.3002114 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 248.6577181 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 248.9878543 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 249.4969819 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 252.0661157 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 255.9241706 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 268.4865238 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 271.3912476 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 274.9042146 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 281.25 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 283.203125 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 285.6242119 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 291.1079746 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 298.8826816 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 303.0018762 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 305.1787916 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 307.9245283 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 309.8591549 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 313.1443299 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 316.7366527 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 316.7701863 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 318.5714286 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 322.8476821 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 325.5894591 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 327.3881499 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 334.4663494 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 334.6153846 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 335.8490566 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 346.2282398 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 350.0294638 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 351.369863 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 364.2140468 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 370.9265176 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 371.1967546 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 380.236305 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 401.3722127 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 408.1237911 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 425.6017505 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 429.1287386 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 433.7592468 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 451.3358779 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 486.9775893 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 492.7536232 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 494.7033898 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 529.0806754 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 538.3615085 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 565 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | lyxitol | 603 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | lyxitol | 624.7443763 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 640 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | lyxitol | 658 | Peak area | Group 1 - Subcutaenous Fat |
| GCMS positive ion mode | lyxitol | 664.7058824 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 670.212766 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 726.3263936 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 749.2877493 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 766 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | lyxitol | 773 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | lyxitol | 904 | Peak area | Method Blanks and BioRec Plasma - QC |
| GCMS positive ion mode | lyxitol | 1332.594235 | Peak area | Group 2 - Visceral Fat |
| GCMS positive ion mode | lyxitol | 2742.715232 | Peak area | Group 2 - Visceral Fat |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|